Fesoterodine

From Wikipedia, the free encyclopedia

Fesoterodine
Systematic (IUPAC) name
[2-[(1R)-3-(Di(propan-2-yl)amino)-1-phenylpropyl]-4-(hydroxymethyl)phenyl] 2-methylpropanoate
Identifiers
CAS number	?
ATC code	G04BD11
PubChem	6918558
Chemical data
Formula	C26H37NO3
Mol. mass	411.58 g/mol
Pharmacokinetic data
Bioavailability	?
Metabolism	?
Half life	?
Excretion	?
Therapeutic considerations
Licence data	EU
Pregnancy cat.	?
Legal status
Routes	Oral

Fesoterodine (INN, brand name Toviaz) is an antimuscarinic drug developed by Schwarz Pharma AG to treat Overactive bladder syndrome.^[1] It was approved by the European Medicines Agency in April 2007.^[2]

[edit] References

v • d • e Urologicals (G04) Acidifiers Ammonium chloride, Calcium chloride Urinary antispasmodics (primarily antimuscarinics) Darifenacin, Emepronium, Fenoverine, Fesoterodine, Flavoxate, Meladrazine, Oxybutynin, Propiverine, Solifenacin, Terodiline, Tolterodine, Trospium For erectile dysfunction prostaglandins: Alprostadil PDE5 inhibitors: Avanafil - Sildenafil - Tadalafil - Udenafil - Vardenafil alpha blockers: Moxisylyte - Phentolamine - Yohimbine others: Apomorphine - Papaverine Other urologicals Acetohydroxamic acid, Collagen, Dimethyl sulfoxide, Magnesium hydroxide, Pentosan polysulfate, Phenazopyridine, Phenyl salicylate, Succinimide For benign prostatic hypertrophy 5α-reductase inhibitors: Dutasteride, Finasteride Alpha blockers: Alfuzosin, Doxazosin, Silodosin, Tamsulosin, Terazosin Herbals: Pygeum africanum, Serenoa repens